20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T60742 | HIV-1 integrase inhibitor 8 | HIV Protease | |
HIV-1 integrase inhibitor 8 is an inhibitor of HIV-1 integrase. Integration is a required step in HIV replication [1]. | |||
T11566 | HIV-1 integrase inhibitor | Others | |
Hiv-1 integrase inhibitor is an effective anti-HIV drug. | |||
T11568 | HIV-1 integrase inhibitor 4 | Others | |
HIV-1 integrase inhibitor 4 is an HIV-1 integrase strand transfer (INST) inhibitor (IC50: 3.7 nM). | |||
T11567 | HIV-1 integrase inhibitor 3 | Others | |
HIV-1 integrase inhibitor 3 is an HIV-1 integrase strand transfer (INST) inhibitor (IC50: 2.7 nM). | |||
T11565 | HIV-1 integrase inhibitor 7 | Others | |
HIV-1 integrase inhibitor 7 is a potent HIV-1 integrase inhibitor (IC50: 33.3 nM). | |||
T62156 | HIV-1 integrase inhibitor 9 | ||
HIV-1 integrase inhibitor 9 (compound 8a) is a potent inhibitor of HIV-1 RNase H (IC50: 12.3 μM) and has antiviral effects. | |||
T72162 | HIV-1 integrase inhibitor 10 | ||
HIV-1 Integrase Inhibitor 10, an orally active allosteric integrase inhibitor (ALLINI), effectively inhibits the NLRepRluc virus's viral outgrowth in MT-2 cells, exhibiting EC50 values of 3-5 nM. This compound is utilize... | |||
T64096 | Integrase-LEDGF/p75 allosteric inhibitor 1 | ||
Integrase-LEDGF/p75 allosteric inhibitor 1 is an orally active integrase-LEDGF/p75 (IN-LEDGF/p75) allosteric inhibitor. It inhibits HIV-1 DNA integration and exhibits antiviral effects, acting on the HIV-1 recombinant mo... | |||
T15483 | LEDGIN6 | HIV-1 integrase inhibitor 2 | Others |
HIV-1 integrase inhibitor 2 is used for the treatment of human immunodeficiency virus (HIV) infection. | |||
T4182 | Lavendustin B | Tyrosinase , transporter , HIV Protease | |
Lavendustin B is a Tyrosine Kinase Inhibitor and an inhibitor of HIV-1 integrase (IN) interaction with its cognate cellular cofactor, lens epithelium-derived growth factor (LEDGF/p75). | |||
T4493 | Bictegravir | GS-9883 | HIV Protease |
Bictegravir (GS-9883) is a potent inhibitor of HIV-1 integrase (IC50: 7.5 nM). | |||
T6420 | BMS-707035 | HIV Protease | |
BMS-707035 is a specific HIV-I integrase (IN) inhibitor with IC50 of 15 nM. Phase 2. | |||
T2239L | Raltegravir | MK-0518 | HIV Protease , Integrase |
Raltegravir (MK-0518) is a pyrrolidinone derivative and HIV INTEGRASE INHIBITOR that is used in combination with other ANTI-HIV AGENTS for the treatment of HIV INFECTION. | |||
T0753 | Salicylanilide | WR10019,2-Hydroxybenzanilide | HIV Protease , Reverse Transcriptase |
Salicylanilide (2-Hydroxybenzanilide)s are a group of compounds with antiviral potency, antibacterial and antifungal activities. | |||
TN2158 | Robinetin | 3,3',4',5',7-Pentahydroxyflavone | Anti-infection , HIV Protease , Antibacterial |
Robinetin (3,3',4',5',7-Pentahydroxyflavone) has antioxidant and antiradical activities, inhibits EYPC membrane lipid peroxidation and HbA glycosylation with high efficiency. | |||
T2239 | Raltegravir potassium | MK 0518 potassium salt,Raltegravir potassium salt | HIV Protease , Integrase |
Raltegravir potassium (MK 0518 potassium salt) salt(MK0518 potassium salt) is a potent integrase (IN) inhibitor, used to treat HIV infection. | |||
T6198 | Dolutegravir | S/GSK1349572,GSK1349572 | HIV Protease |
Dolutegravir (GSK1349572) (IC50=2.7 nM), a two-metal-binding HIV integrase inhibitor, exhibits medium activity against raltegravir-resistant signature mutants Y143R, Q148K, N155H, and G140S/Q148H. | |||
T2329 | Dolutegravir sodium | GSK1349572,GSK-1349572A | HIV Protease |
Dolutegravir sodium (GSK-1349572A) salt(DTG; GSK1349572) is an HIV integrase inhibitor(IC50: 2.7 nM), modest activity against raltegravir-resistant signature mutants Y143R, Q148K, N155H, and G140S/Q148H. | |||
T6098 | Cabotegravir | GSK744,GSK-1265744,S/GSK1265744 | HIV Protease |
Cabotegravir (S/GSK1265744) (GSK744, GSK1265744) is a long-acting HIV integrase inhibitor and inhibits the HIV-1 integrase catalyzed strand transfer reaction (IC50: 3.0 nM). | |||
T2332 | Elvitegravir | GS-9137,EVG,D06677,JTK-303 | HIV Protease |
Elvitegravir (JTK-303) is a Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor. The mechanism of action of elvitegravir is as an HIV Integrase Inhibitor, and Cytochrome P450 2C9 Inducer. |